Welcome to our dedicated page for Healthwarehouse news (Ticker: HEWA), a resource for investors and traders seeking the latest updates and insights on Healthwarehouse stock.
HealthWarehouse.com is an OTCQB-traded healthcare e-commerce company that sells and delivers prescription and over-the-counter medications nationwide through a NABP Approved Digital Pharmacy platform. Company updates commonly cover financial results, prescription volume, direct-to-consumer activity, partner-services revenue, fulfillment capacity, and technology investments focused on patient experience, operational efficiency, and scalability.
Recurring news also addresses business partnerships for prescription and OTC fulfillment, product-catalog changes, cold-chain shipping capabilities, and shifts in categories such as compounded GLP-1 medications. Capital items, including convertible-note maturity changes, appear alongside operating updates for the digital pharmacy business.
HealthWarehouse.com (OTCQB: HEWA) reported a net sales increase of 5% to $4,212,127 for Q3 2021, with prescription sales up 13%. The company posted a loss from operations of $181,031 but achieved positive cash flow with an Adjusted EBITDA of $89,797. The decline in over-the-counter sales by 27% was attributed to decreased website traffic compared to pandemic highs in 2020. Despite the challenges, HealthWarehouse.com plans to expand B2B offerings and invest in technology to enhance customer experience.
HealthWarehouse.com, Inc. (OTC: HEWA) reported a net loss of $181,811 for Q2 2021, a considerable drop from the prior year. Despite a 13% decline in net sales to $3,954,892, the company achieved a positive Adjusted EBITDA of $87,636. Prescription sales rose slightly, while over-the-counter sales fell by 50.5%. Operating expenses reduced by 5.2%. The company transitioned to the OTCQB market to enhance its investment appeal. CEO Joseph Peters highlighted a focus on technology investments and an anticipated sales uptick in the latter half of 2021.
HealthWarehouse.com, Inc. (OTCQB: HEWA) reported a net loss of $131,025 for Q1 2021, an increase from a loss of $68,428 in Q1 2020. Despite this, the company achieved a positive Adjusted EBITDA of $124,114. Net sales declined by 16% to $3,818,285, driven by decreased consumer demand and lower website traffic. Prescription sales fell by 9.9%, and over-the-counter sales decreased by 36.8%. Operating expenses decreased by 5.2%. Gross profit was $2,651,875, reflecting a 7.8% decrease, but gross margin improved to 69.5% through strategic purchasing efforts.
HealthWarehouse.com, Inc. (OTCQB:HEWA) has announced that its common stock will start trading on the OTCQB Market, enhancing investor visibility and potential liquidity. President Joseph Peters positioned this as a significant milestone, stating it could attract greater investor interest compared to the previous OTC Pink Sheets listing. The OTCQB requires companies to meet specific financial and reporting criteria, further strengthening its market position. HealthWarehouse.com offers affordable online pharmacy services nationwide, supporting its mission to deliver quality healthcare.
HealthWarehouse.com, Inc. (OTC:HEWA) reported a net income of $641,326 and net sales of $17,178,985 for 2020, marking a net income turnaround from a loss of $99,400 in 2019. Adjusted EBITDA was $593,744, down from $712,312 the previous year. The company saw a 9% rise in total net sales from 2019, driven by a 25% increase in over-the-counter sales amid COVID-19 demand. Operating expenses rose 12%, primarily due to staffing and variable costs. HealthWarehouse.com is preparing to launch new pharmacy software in Q3 2021, aiming to enhance operational efficiency.